dr. Edel Herbitya, Sp.PD., telah bergabung di Pusat Kanker Nasional RS Kanker Dharmais
RESEARCH AND PUBLICATION
- 2019 Endoscopic Appearance Among Patients with Chronic Diarrhea : Jakarta Experience sebagai Co-Author Dipresentasikan di Asia Pacific Digestive Week (APDW) 2019, India
- 2016 Prognostic Factors and Survival of Lung Cancer Patients with Malignant Pleural Effusions sebagai First Author Journal Respirology (2016) Volume 21 (Suppl. 3) page 121, DOI : 10.1111/resp.12939_15
- 2016 Clinicopathological Profile, Epidermal Growth Factor Receptor Mutation and One-Year Survival of Non-Small Cell Lung Cancer in Dharmais National Cancer Center Hospital-Indonesia sebagai First Author Dipresentasikan di The IASLC Asia Pacific Lung Cancer Conference (APLCC) 2016, Chiang Mai, Thailand
- 2015 Plasminogen Activator Inhibitor-1 (PAI-1) and Plasma Fibrinogen as Prognostic Factors in Adenocarcinoma Lung Cancer Patients sebagai First Author Dipresentasikan di The 20th Congress of the Asian Pacific Society of Respirology (APSR) 2015, Kuala Lumpur, Malaysia
- 2015 Correlation Between Soluble uPAR and D-dimer Level with Survival and Distant Metastasis in Lung Adenocarcinoma : A Preliminary Study sebagai Co-Author Dipresentasikan di The 20th Congress of the Asian Pacific Society of Respirology (APSR) 2015, Kuala Lumpur, Malaysia
- 2015 Profile of Cancer and HIV/AIDS at Dharmais Cancer Hospital sebagai CoAuthor Dipresentasikan di 23rd Asia Pacific Cancer Conference (APCC) 2015, Bali, Indonesia
|
2017 – 2022 Spesialis Penyakit Dalam Fakultas Kedokteran, Universitas Indonesia
2011 – 2012 Dokter Umum Fakultas Kedokteran, Universitas Airlangga
2007 – 2011 Sarjana Kedokteran Fakultas Kedokteran, Universitas Airlangga |
